One variant limited the brain’s ability to use glucose.

Boosting both neurogenesis and a brain-derived growth factor can mimic the cognitive benefits of exercise in a mouse mode of Alzheimer’s disease.

In a clinical trial, patients on the highest injected dose had 30 percent less cognitive decline over time than people on a placebo.

In a longitudinal study, researchers find that elderly people with higher pressure were more likely to show signs of Alzheimer’s disease in brain tissue.

The test uses levels of plasma amyloid-β to estimate the buildup of protein plaques in the brain.

The elimination of these glia in the mouse brain ameliorated the development of Parkinsonian neuropathologies induced by the pesticide toxin paraquat.  

The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.

Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s.